BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Highland Instruments, Inc. , Announces Presentation Of "Effects Of Electrosonic Stimulation On The Perception Of Chronic Pain Due To Osteoarthritis Of The Knee."


12/9/2013 6:43:10 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

BOSTON, Dec. 9, 2013 /PRNewswire/ -- Highland Instruments, Inc., ("Highland") today announced presentation of "Effects of Electrosonic Stimulation ("ESStim") on the Perception of Chronic Pain Due to Osteoarthritis of the Knee", discussing Highland Instruments' ESStim technology during the 5th International Symposium on Neuromodulation, held September 16-18, 2013 at Mackenzie Presbyterian University, Sao Paulo, Brazil. This research was conducted at the Spaulding Rehabilitation ("Spaulding") Hospital's Laboratory of Neuromodulation (Boston). Felipe Fregni1, MD, PhD, MPH, was Lead Clinical Investigator. Dr. Fregni is the Director of the Laboratory of Neuromodulation at Spaulding and Associate Professor of PM&R and Neurology at Harvard Medical School.

Dr. Felipe Fregni commented, "Our preliminary analysis in a series of 18 patients with osteoarthritis ("OA") of the knee demonstrated that ESStim has shown positive results in alleviating chronic pain in OA patients. Patients that received Active ESStim showed significant effects lasting up to four weeks post stimulation."

About Osteoarthritis ("OA")of the Knee

OA is the most common form of knee arthritis in which the joint cartilage gradually wears away. OA affects nearly 27 million Americans (12.1% of the U.S. adult population)2 and more than 10 million have OA in one or both knees3. The combined annual costs of knee and hip arthroplasty in 2007 are estimated to have been ~$15.6B based on data compiled by the Healthcare Costs and Utilization Project4.

About ESStim

ESStim5 is an innovative noninvasive brain stimulation technology that combines independently controlled electromagnetic and ultrasonic fields. The combined fields focus and boost neurostimulation currents via tuned electromechanical coupling in neural tissue. Preliminary ESStim studies have demonstrated a significantly improved duration and magnitude of stimulation effect compared to other reported dose-matched noninvasive stimulation modalities in electrophysiology, metabolic, and behavioral studies.

About the 5th International Symposium on Neuromodulation

The International Symposium on Neuromodulation in partnership with the Mackenzie Presbyterian University (Sao Paulo, Brazil) is an international gathering of clinical and scientific experts in the field of neuromodulation.

About Spaulding Rehabilitation Hospital

Spaulding is affiliated with Harvard Medical School, the Massachusetts General Hospital Institute of Health Professionals, and Partners Health Care System. Spaulding is one of the largest rehabilitation hospitals of its kind in the United States, with 296 beds, more than 3000 inpatient admissions per year and a large outpatient service.

About Highland Instruments, Inc.

Highland Instruments is a privately held medical device company pioneering the development and commercialization of ESStim, an innovative noninvasive electrosonic brain stimulation technology for the treatment of brain-based movement disorders as well as chronic pain management.

1 Dr. Fregni has no financial interest in Highland Instruments.
2 Arthritis Rheum. 2008;58(1):26-35.
3http://www.synviscone.com/about-knee-osteoarthritis.aspx
4http://hcupnet.ahrq.gov/HCUPnet.jsp
5 Patents Issued and Pending

Contact:

Bill Edelman, COB

bill.edelman@highlandinstruments.com

(781) 436-0509

Tim Wagner, PhD, CSO

twagner@highlandinstruments.com

(617) 504-6031

SOURCE Highland Instruments, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES